SAMRC launches new initiatives to study antimicrobial resistance. Researchers warn of a looming public health crisis if drug resistance is unchecked.
Antimicrobial resistance (AMR) is emerging as one of South Africa’s greatest health threats. The SAMRC has launched a multi-disciplinary program to study resistance patterns and develop new therapies. Hospitals report rising cases of drug-resistant TB and bacterial infections. Researchers emphasize that misuse of antibiotics in both healthcare and agriculture accelerates resistance. The program includes genomic studies, drug discovery, and public awareness campaigns. International partners collaborate to share data and funding. Experts warn that without urgent action, common infections could become untreatable. The SAMRC initiative reflects South Africa’s leadership in global health research, but success depends on policy enforcement and public cooperation.
